Response by Rowin et al to Letter Regarding Article, “Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy”
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
We appreciate the comments by Drs Wang and Zhao regarding our recent article on atrial fibrillation (AF) in patients with hypertrophic cardiomyopathy (HCM).1 Distinctive from ischemic heart disease, inappropriate implantable cardioverter-defibrillator therapy in HCM appears to be unassociated with cardiovascular morbidity or mortality or transformation to heart failure deterioration.2–5 Specifically, 19 …